In a U.S. market where fewer than 2% of EMS agencies have implemented prehospital blood programs—and over 70% of those rely on Delta Development Team (DDT) systems—DDT is emerging as the clear leader in a rapidly expanding space. The company announced the successful close of its Series A3 funding round, marking a major milestone in its growth trajectory.

Health Technology Insights: NJ Taps Garden State Venture Partners for MedTech Growth

Unlike many startups navigating a tight funding landscape, DDT completed its extended Series A round in just nine months. This momentum is a direct result of its increasing adoption across both civilian and military healthcare sectors, its growing reputation as the gold standard in cold chain technology, and its alignment with evolving protocols that prioritize earlier access to blood in the field.

“This market is transforming fast—and we’re not just keeping pace; we’re driving the shift,” said Montgomery Leija, CEO of Delta Development Team. “From military partnerships to frontline EMS units, our systems are becoming foundational infrastructure for evolving prehospital blood programs.”

The Series A3 round was backed by a mix of strategic capital and non-dilutive funding, including support from the U.S. Air Force’s TACFI (SBIR) program. This funding structure enables DDT to scale quickly while minimizing dilution and operational risk.

Health Technology Insights: Bio Usawa, DEK Partner to Boost Biotech Access in West Africa

Investors

Amongst other investors, this round attracted a consortium of top angel networks known for backing breakthrough healthcare and deep-tech ventures:

  • Desert Angels – A cornerstone of the Southwest’s startup scene, Desert Angels has invested over $65 million in more than 165 companies. Their involvement signals strong regional and national belief in Delta’s mission.
  • Arizona Tech Investors (ATI) – With a focus on high-growth innovation across Arizona and beyond, ATI’s members bring not only capital but also a deep bench of technical and operational expertise.
  • Baylor Angel Network (BAN) – BAN’s unique blend of capital and analytical rigor—powered in part by its student analyst program—adds another layer of strategic insight to Delta’s investor base.
  • Pasadena Angels – A force in Southern California’s innovation ecosystem, the Pasadena Angels contribute early-stage funding and mentorship, backed by a network of seasoned executives and entrepreneurs.
  • Central Texas Angel Network (CTAN) – Among the most active angel groups in the country, CTAN brings deep experience in scaling early-stage ventures and unlocking growth in complex markets.

Health Technology Insights: Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Schizophrenia

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source- PR Newswire